Larvol Delta - BlossomHill-Therapeutics-to-Present-Updated-Data-from-Ongoing-Phase-12-SOLARA-Trial-of-its-Macrocyclic-OMNIEGFR-Inhibitor-BH30643-in-EGFRmutant-NSCLC-at-the-2026-World-Conference-on-Lung-Cancer

BH-30643 - BlossomHill Therap

https://www.globenewswire.com/news-release/2026/09/01/3353953/0/en/blossomhill-therapeutics-to-present-updated-data-from-ongoing-phase-1-2-solara-trial-of-its-macrocyclic-omni-egfr-inhibitor-bh-30643-in-egfr-mutant-nsclc-at-the-2026-world-conferen.html

Sep 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next